Pfizer

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE182A01018
NSEID: PFIZER
BSEID: 500680
View on NSE | View on BSE

INR

4,877.60

-3 (-0.06%)

BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 53.97 k

{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,877.60",
    "chg": -3,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "4,880.60",
    "mcapval": "22,454.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE182A01018",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "18:33 PM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "53.97 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-market-signals-4144705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PfizerLtd_technicaldot_4144705.png",
        "date": "2026-08-10 08:03:48",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bullish to mildly bearish territory. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical indicators present a complex picture for investors navigating the current market environment."
      },
      {
        "title": "Pfizer Ltd Gains 0.88%: 3 Key Technical and Financial Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-gains-088-3-key-technical-and-financial-factors-driving-the-week-4143250",
        "imagepath": "",
        "date": "2026-08-08 14:04:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.4,915.45 (+1.92%) amid positive sentiment</p>\n                    <p><strong>4 Aug:</strong> Mojo Grade upgraded to Hold by MarketsMOJO on improved financial and technical metrics</p>\n                    <p><strong>5 Aug:</strong> Technical momentum shifts to mildly bullish despite a slight daily price dip</p>\n                    <p><strong>7 Aug:</strong> Week closes at Rs.4,865.10, up 0.88% for the week but slightly down on the day (-0.74%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,822.80</div></div>\n   ..."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-4137089",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PfizerLtd_technicaldot_4137089.png",
        "date": "2026-08-05 08:06:07",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in its daily price, the stock’s technical indicators present a nuanced picture, reflecting both positive momentum and cautionary signals for investors."
      },
      {
        "title": "Pfizer Ltd. Upgraded to Hold by MarketsMOJO on Improved Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-upgraded-to-hold-by-marketsmojo-on-improved-financial-and-technical-metrics-4135860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PfizerLtd_mojoScore_4135860.png",
        "date": "2026-08-04 08:57:59",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 3 August 2026. This change reflects notable improvements across financial performance, valuation metrics, and technical indicators, signalling a more stable outlook for the company amid mixed long-term growth prospects."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Sideways; Mojo Grade Upgraded to Hold",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-sideways-mojo-grade-upgraded-to-hold-4135104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PfizerLtd_technicaldot_4135104.png",
        "date": "2026-08-04 08:08:36",
        "description": "Pfizer Ltd. has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a nuanced market sentiment. With a recent upgrade from a Sell to a Hold rating and a 1.92% gain on the day, the pharmaceutical small-cap is navigating a complex technical landscape amid broader sector recovery and mixed market signals."
      },
      {
        "title": "Pfizer Ltd Gains 4.44%: 2 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-gains-444-2-key-factors-driving-the-weekly-rally-4131571",
        "imagepath": "",
        "date": "2026-08-01 14:03:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens week at Rs.4,690.15, up 1.57%</p>\n                    <p><strong>28 Jul:</strong> Q1 FY27 results reveal strong profit growth, stock rises 0.33%</p>\n                    <p><strong>29 Jul:</strong> Quarterly turnaround confirmed, stock gains 1.04%</p>\n                    <p><strong>30 Jul:</strong> Continued positive momentum, stock up 0.93%</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.4,822.80, up 0.49%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,690.15</div></div>\n                    <div class..."
      },
      {
        "title": "Are Pfizer Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-pfizer-ltd-latest-results-good-or-bad-4127142",
        "imagepath": "",
        "date": "2026-07-29 19:19:37",
        "description": "Pfizer Ltd.'s latest financial results for Q1 FY27 reveal a company demonstrating operational strength amidst a competitive landscape. The net sales reached ₹653.17 crores, reflecting a sequential growth of 3.80% and an annual increase of 8.31%. This growth trajectory indicates consistent demand across its portfolio of specialized medicines, which spans 15 therapeutic areas. The company achieved a net profit of ₹204.47 crores, marking a 2.33% increase from the previous quarter and a 6.63% rise year-on-year.\n\nA notable highlight from the results is the operating margin, which reached 37.90%, the highest recorded in the company's history. This margin expansion illustrates effective cost management and operational efficiency, even as employee costs rose. The return on equity stood at a robust 18.05%, indicating strong capital efficiency.\n\nDespite these positive operational metrics, Pfizer faces challenges rega..."
      },
      {
        "title": "Pfizer Ltd. Reports Strong Quarterly Financial Turnaround Amid Positive Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-reports-strong-quarterly-financial-turnaround-amid-positive-market-momentum-4124925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PfizerLtd_fintrenddot_4124925.png",
        "date": "2026-07-29 08:00:22",
        "description": "Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, driven by record-breaking revenue and profitability metrics, signalling a potential turnaround despite a challenging broader market environment."
      },
      {
        "title": "Pfizer Ltd. Q1 FY27: Strong Profit Growth Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/pfizer-ltd-q1-fy27-strong-profit-growth-masks-valuation-concerns-4124696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Pfizer_quaterlyResult_4124696.png",
        "date": "2026-07-28 20:01:55",
        "description": "Pfizer Ltd. reported a net profit of ₹204.47 crores for Q1 FY27 (quarter ended June 2026), marking a sequential increase of 2.33% from ₹199.82 crores in Q4 FY26 and a year-on-year growth of 6.63% from ₹191.75 crores in Q1 FY26. The pharmaceutical major, with a market capitalisation of ₹21,584 crores, demonstrated resilient operational performance with its highest-ever quarterly revenue and operating profit margins, though investors remain cautious as the stock trades 19.95% below its 52-week high of ₹5,878.55."
      }
    ],
    "total": 391,
    "sid": "970356",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "details": "Pfizer Limited has submitted to the Exchange a copy of Disclosure of Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Pfizer Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "Pfizer Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Pfizer Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Pfizer Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Pfizer Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "05-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>750%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-08-10 08:03:48

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bullish to mildly bearish territory. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical indicators present a complex picture for investors navigating the current market environment.

Read full news article

Pfizer Ltd Gains 0.88%: 3 Key Technical and Financial Factors Driving the Week

2026-08-08 14:04:28

Key Events This Week

3 Aug: Stock opens strong at Rs.4,915.45 (+1.92%) amid positive sentiment

4 Aug: Mojo Grade upgraded to Hold by MarketsMOJO on improved financial and technical metrics

5 Aug: Technical momentum shifts to mildly bullish despite a slight daily price dip

7 Aug: Week closes at Rs.4,865.10, up 0.88% for the week but slightly down on the day (-0.74%)

Week Open

Rs.4,822.80

...

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-08-05 08:06:07

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in its daily price, the stock’s technical indicators present a nuanced picture, reflecting both positive momentum and cautionary signals for investors.

Read full news article

Pfizer Ltd. Upgraded to Hold by MarketsMOJO on Improved Financial and Technical Metrics

2026-08-04 08:57:59

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 3 August 2026. This change reflects notable improvements across financial performance, valuation metrics, and technical indicators, signalling a more stable outlook for the company amid mixed long-term growth prospects.

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Sideways; Mojo Grade Upgraded to Hold

2026-08-04 08:08:36

Pfizer Ltd. has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a nuanced market sentiment. With a recent upgrade from a Sell to a Hold rating and a 1.92% gain on the day, the pharmaceutical small-cap is navigating a complex technical landscape amid broader sector recovery and mixed market signals.

Read full news article

Pfizer Ltd Gains 4.44%: 2 Key Factors Driving the Weekly Rally

2026-08-01 14:03:31

Key Events This Week

27 Jul: Stock opens week at Rs.4,690.15, up 1.57%

28 Jul: Q1 FY27 results reveal strong profit growth, stock rises 0.33%

29 Jul: Quarterly turnaround confirmed, stock gains 1.04%

30 Jul: Continued positive momentum, stock up 0.93%

31 Jul: Week closes at Rs.4,822.80, up 0.49%

Week Open

Rs.4,690.15

Read full news article

Are Pfizer Ltd. latest results good or bad?

2026-07-29 19:19:37

Pfizer Ltd.'s latest financial results for Q1 FY27 reveal a company demonstrating operational strength amidst a competitive landscape. The net sales reached ₹653.17 crores, reflecting a sequential growth of 3.80% and an annual increase of 8.31%. This growth trajectory indicates consistent demand across its portfolio of specialized medicines, which spans 15 therapeutic areas. The company achieved a net profit of ₹204.47 crores, marking a 2.33% increase from the previous quarter and a 6.63% rise year-on-year. A notable highlight from the results is the operating margin, which reached 37.90%, the highest recorded in the company's history. This margin expansion illustrates effective cost management and operational efficiency, even as employee costs rose. The return on equity stood at a robust 18.05%, indicating strong capital efficiency. Despite these positive operational metrics, Pfizer faces challenges rega...

Read full news article

Pfizer Ltd. Reports Strong Quarterly Financial Turnaround Amid Positive Market Momentum

2026-07-29 08:00:22

Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, driven by record-breaking revenue and profitability metrics, signalling a potential turnaround despite a challenging broader market environment.

Read full news article

Pfizer Ltd. Q1 FY27: Strong Profit Growth Masks Valuation Concerns

2026-07-28 20:01:55

Pfizer Ltd. reported a net profit of ₹204.47 crores for Q1 FY27 (quarter ended June 2026), marking a sequential increase of 2.33% from ₹199.82 crores in Q4 FY26 and a year-on-year growth of 6.63% from ₹191.75 crores in Q1 FY26. The pharmaceutical major, with a market capitalisation of ₹21,584 crores, demonstrated resilient operational performance with its highest-ever quarterly revenue and operating profit margins, though investors remain cautious as the stock trades 19.95% below its 52-week high of ₹5,878.55.